Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000797753 | SCV000937332 | uncertain significance | Progressive myoclonic epilepsy type 8 | 2021-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004897655 | SCV005554329 | uncertain significance | not specified | 2024-08-19 | criteria provided, single submitter | clinical testing | The c.250C>A (p.P84T) alteration is located in exon 2 (coding exon 2) of the CERS1 gene. This alteration results from a C to A substitution at nucleotide position 250, causing the proline (P) at amino acid position 84 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |